Back to results
Completed

Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

NCT03445637

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Pfizer

Seoul, South Korea

View on ClinicalTrials.gov
Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE® — TrialFind